Clinical Trial Update: Efficacy and Safety of 30% Supramolecular Salicylic Acid Combined With Supramolecular Active Zinc in the Treatment of Malassezia Folliculitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing efficacy and safety of 30% supramolecular salicylic acid combined with supramolecular active zinc for Malassezia folliculitis h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malassezia Folliculitis

Drugs mentioned

• 30% supramolecular salicylic acid combined with supramolecular active zinc

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Malassezia Folliculitis | Phase 4 | Status: COMPLETED